Find latest Skin videos · 200+ videos

This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub
A

ESMO 2024 Insights: Nivo + Ipi ± ASTX727 in Anti-PD-1 Resistant Metastatic Melanoma - NIBIT-ML1 Ph2 Study

By 2024 ESMO Annual Meeting Insights Hub FEATURING Anna Maria Di Giacomo
By 2024 ESMO Annual Meeting Insights Hub FEATURING Anna Maria Di Giacomo
76 views
September 20, 2024
Comments 0
Login to view comments. Click here to Login

2024 ESMO Annual Meeting Insights Hub: Skin Videos

17:12

ESMO 2024 Summary: Long-Term Survival Outcomes in Advanced Melanoma …

2024 ESMO Annual Meeting Insights Hub

J. Hassel

34 views
08:45

ESMO 2024 Insights: Follow-Up Brain Imaging in Melanoma Patients Wit…

2024 ESMO Annual Meeting Insights Hub

I. Ozdamar

15 views
18:24

ESMO 2024 Summary: Neoadjuvant Immunotherapy as the Future of Melano…

2024 ESMO Annual Meeting Insights Hub

A. van Akkooi

63 views
View All

Related Videos

09:26

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Oncology Data Advisor

M. Hadfield

344 views
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

2.0K views
35:23

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

S. Patel

807 views
09:33

ESMO 2024 Summary: Metastatic Melanoma Highlights

2024 ESMO Annual Meeting Insights Hub

C. Blank

211 views
22:58

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

Tarek Haykal

735 views
20:07

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

268 views
14:42

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

Jeff Yorio

578 views
24:14

Advances in the Treatment of Melanoma

Masterclasses in Dermatology

D. Fisher

814 views
15:49

New Frontiers in Oncology: Advanced Diagnostics and Therapeutics

Springer Healthcare IME

S. Peters

177 views
12:17

ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials

2024 ESMO Annual Meeting Insights Hub

D. Johnson

195 views
11:05

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

2024 ASCO® Annual Meeting Insights Hub

D. Johnson

518 views
25:29

ASCO® 2024 Summary: "Insights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

O. Hamid

469 views
09:54

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcome…

2024 ASCO® Annual Meeting Insights Hub

H. Tawbi

432 views
12:46

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Stanford Medicine

A. Betof Warner

1.0K views
17:01

Biomarkers for Immunotherapy in Melanoma: Where Are We Now?

Vanderbilt University Medical Center (VUMC)

D. Johnson

107 views
09:07

New

Year in Review 2024 - Melanoma

Oncology 2024 Year in Review

A. van Akkooi

106 views
28:32

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

423 views
28:57

Systemic Therapies for Melanoma and Immune Related Adverse Effects (…

Melanoma Research Foundation

S. Chandra

41 views
14:32

2024 SMR Congress Insights: Key Takeaways of Important Trials in Mel…

Roswell Park Comprehensive Cancer Center

I. Puzanov

127 views
24:27

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

2024 ASCO® Annual Meeting Insights Hub

Z. Eroglu

327 views
AUTOPLAY